Tag Archives: Therapeutic Goods Administration

Another seven cases of a rare blood clotting condition in Australia have been linked to the AstraZeneca vaccine. The Therapeutic Goods Administration announced the new cases in its weekly COVID 19 vaccine safety briefing. The authority said three cases were confirmed as a syndrome involving blood clots coupled with a low platelet count, and fourContinue reading “Another Seven Blood Clot Cases Are Linked To The AstraZeneca Jab”